This report contains market size and forecasts of Pharmaceutical Contract Development and Manufacturing in Global, including the following market information:
Global Pharmaceutical Contract Development and Manufacturing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Pharmaceutical Contract Development and Manufacturing market was valued at 124880 million in 2021 and is projected to reach US$ 189210 million by 2028, at a CAGR of 6.1% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Pharmaceutical Manufacturing Services Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pharmaceutical Contract Development and Manufacturing include Thermo Fisher Scientific Inc., Catalent, Inc., Lonza Group Ltd, Recipharm AB, Vetter Pharma International GMBH, FAMAR Health Care Services, AbbVie Inc., Aenova Group and Consort Medical plc, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pharmaceutical Contract Development and Manufacturing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pharmaceutical Contract Development and Manufacturing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Pharmaceutical Contract Development and Manufacturing Market Segment Percentages, by Type, 2021 (%)
Pharmaceutical Manufacturing Services
Biologics Manufacturing Services
Drug Development Services
Global Pharmaceutical Contract Development and Manufacturing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Pharmaceutical Contract Development and Manufacturing Market Segment Percentages, by Application, 2021 (%)
Big Pharma
Small Pharma
Generic Pharma
CRO
Global Pharmaceutical Contract Development and Manufacturing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Pharmaceutical Contract Development and Manufacturing Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pharmaceutical Contract Development and Manufacturing revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Pharmaceutical Contract Development and Manufacturing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Thermo Fisher Scientific Inc.
Catalent, Inc.
Lonza Group Ltd
Recipharm AB
Vetter Pharma International GMBH
FAMAR Health Care Services
AbbVie Inc.
Aenova Group
Consort Medical plc
Almac Group
Siegfried Holding AG
Boehringer Ingelheim International GmbH
Evonik Industries AG